Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Change in Cash (2023 - 2025)

Cannabis Bioscience International Holdings' Change in Cash history spans 3 years, with the latest figure at -$91.0 for Q4 2025.

  • For Q4 2025, Change in Cash fell 375.76% year-over-year to -$91.0; the TTM value through Nov 2025 reached -$870.0, down 230.83%, while the annual FY2025 figure was $12197.0, 249.51% up from the prior year.
  • Change in Cash for Q4 2025 was -$91.0 at Cannabis Bioscience International Holdings, up from -$12729.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $12404.0 in Q2 2025 and bottomed at -$16742.0 in Q2 2023.
  • The 3-year median for Change in Cash is -$65.0 (2024), against an average of -$1996.4.
  • The largest YoY upside for Change in Cash was 31905.13% in 2025 against a maximum downside of 6048.13% in 2025.
  • A 3-year view of Change in Cash shows it stood at -$4409.0 in 2023, then soared by 100.75% to $33.0 in 2024, then tumbled by 375.76% to -$91.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Change in Cash are -$91.0 (Q4 2025), -$12729.0 (Q3 2025), and $12404.0 (Q2 2025).